Use of a rare disease patient registry in long-term post-authorisation drug studies

9 Minuten

6.49 MB

Podcast

Podcaster

The Lancet Respiratory Medicine in conversation with

Wissenschaft , Bildung , Gesundheit & Fitness

Beschreibung

vor 7 Jahren

Dr. Diana Bilton joins The Lancet Respiratory Medicine to discuss
how the use of rare disease patient registries helps with long
term drug studies after drug authorisation.

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv